Corona Remedies’ Q2FY26 profit grows by 21.8% YoY, Revenue at...
Mumbai: Emerging pharma major Corona Remedies has reported a strong financial performance for the second quarter of Financial Year 2025-26, with its profit reaching ₹52.32 crore growing 21.8% from the...
